$AAQL
Antiaging Quantum Living Inc.

2023 Q1 Form 10-Q Financial Statement

#000149315223004389 Filed on February 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q1
Revenue $4.000K $2.400K
YoY Change 185.71% 33.33%
Cost Of Revenue $0.00
YoY Change
Gross Profit $4.000K $2.400K
YoY Change 344.44% 33.33%
Gross Profit Margin 100.0% 100.0%
Selling, General & Admin $10.77K $6.060K
YoY Change -46.7% -36.21%
% of Gross Profit 269.3% 252.5%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.00 $40.00
YoY Change 166.67%
% of Gross Profit 2.0% 1.67%
Operating Expenses $10.77K $6.060K
YoY Change -46.7% -36.21%
Operating Profit -$6.772K -$3.660K
YoY Change -64.93% -52.47%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.772K -$3.660K
YoY Change -64.93% -46.49%
Income Tax
% Of Pretax Income
Net Earnings -$6.772K -$3.660K
YoY Change -64.93% -46.49%
Net Earnings / Revenue -169.3% -152.5%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$122.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $900.00 $14.27K
YoY Change -94.19% -18.46%
Cash & Equivalents $354.00 $901.00 $14.27K
Short-Term Investments
Other Short-Term Assets $510.00
YoY Change
Inventory
Prepaid Expenses $506.00
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $354.00 $1.407K $14.27K
YoY Change -97.52% -90.92% -79.13%
LONG-TERM ASSETS
Property, Plant & Equipment $540.00 $619.00 $854.00
YoY Change -36.77% -30.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $540.00 $619.00 $854.00
YoY Change -36.77% -30.45%
TOTAL ASSETS
Total Short-Term Assets $354.00 $1.407K $14.27K
Total Long-Term Assets $540.00 $619.00 $854.00
Total Assets $894.00 $2.026K $15.12K
YoY Change -94.09% -87.63% -77.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $901.00 $600.00
YoY Change -88.0%
Accrued Expenses $901.00
YoY Change
Deferred Revenue $2.800K $4.000K $5.600K
YoY Change -50.0%
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $76.30K $59.00K
YoY Change
Total Short-Term Liabilities $87.00K $80.90K $64.60K
YoY Change 34.68% 886.59% -13.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $87.00K $80.90K $64.60K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $87.00K $80.90K $64.60K
YoY Change 34.68% 30.06% -13.17%
SHAREHOLDERS EQUITY
Retained Earnings -$276.3K -$269.1K -$239.7K
YoY Change 15.28%
Common Stock $30.00K $30.00K $30.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$86.11K -$78.87K -$49.48K
YoY Change
Total Liabilities & Shareholders Equity $894.00 $2.026K $15.12K
YoY Change -94.09% -87.63% -77.88%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q1
OPERATING ACTIVITIES
Net Income -$6.772K -$3.660K
YoY Change -64.93% -46.49%
Depreciation, Depletion And Amortization $80.00 $40.00
YoY Change 166.67%
Cash From Operating Activities -$5.800K -$4.650K
YoY Change -63.01% -51.05%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$1.580K
YoY Change
Cash From Investing Activities $0.00 -$1.580K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.400K 5.000K
YoY Change -131.76%
NET CHANGE
Cash From Operating Activities -5.800K -4.650K
Cash From Investing Activities 0.000 -1.580K
Cash From Financing Activities 5.400K 5.000K
Net Change In Cash -400.0 -1.230K
YoY Change -98.78% -87.05%
FREE CASH FLOW
Cash From Operating Activities -$5.800K -$4.650K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$5.800K -$4.650K
YoY Change -63.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001672571
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q4 us-gaap Selling Expense
SellingExpense
usd
CY2021Q4 us-gaap Selling Expense
SellingExpense
usd
us-gaap Selling Expense
SellingExpense
usd
us-gaap Selling Expense
SellingExpense
usd
CY2022Q4 us-gaap Interest Income Other
InterestIncomeOther
usd
CY2021Q4 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
usd
CY2022Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56157
dei Entity Registrant Name
EntityRegistrantName
Achison Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2643986
dei Entity Address Address Line1
EntityAddressAddressLine1
135-22 Northern Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
2nd Fl
dei Entity Address City Or Town
EntityAddressCityOrTown
Flushing
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11354
dei City Area Code
CityAreaCode
(917)
dei Local Phone Number
LocalPhoneNumber
470-5393
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29995000 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
901 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14269 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
506 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1407 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
14269 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
619 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
854 usd
CY2022Q4 us-gaap Assets
Assets
2026 usd
CY2022Q1 us-gaap Assets
Assets
15123 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
600 usd
CY2022Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
76300 usd
CY2022Q1 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
59000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4000 usd
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5600 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
80900 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
64600 usd
CY2022Q4 us-gaap Liabilities
Liabilities
80900 usd
CY2022Q1 us-gaap Liabilities
Liabilities
64600 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-269099 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239702 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-78874 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2026 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15123 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4000 usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1400 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12400 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5000 usd
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
500 usd
us-gaap Cost Of Revenue
CostOfRevenue
1100 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
4000 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
900 usd
us-gaap Gross Profit
GrossProfit
12400 usd
us-gaap Gross Profit
GrossProfit
3900 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10772 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20210 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41797 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45253 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
10772 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
20210 usd
us-gaap Operating Expenses
OperatingExpenses
41797 usd
us-gaap Operating Expenses
OperatingExpenses
45253 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6772 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-19310 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-29397 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-41353 usd
us-gaap Interest Income Other
InterestIncomeOther
1574 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1574 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6772 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-19310 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29397 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39779 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-6772 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-19310 usd
us-gaap Net Income Loss
NetIncomeLoss
-29397 usd
us-gaap Net Income Loss
NetIncomeLoss
-39779 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
us-gaap Net Income Loss
NetIncomeLoss
-22625 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-72102 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-6772 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-78874 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-6041 usd
us-gaap Net Income Loss
NetIncomeLoss
-20469 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-26510 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-19310 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-45820 usd
us-gaap Net Income Loss
NetIncomeLoss
-29397 usd
us-gaap Net Income Loss
NetIncomeLoss
-39779 usd
us-gaap Depreciation
Depreciation
236 usd
us-gaap Depreciation
Depreciation
64 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
507 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1574 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
600 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1600 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-200 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-30669 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36489 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
950 usd
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
52437 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51487 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17300 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
17000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17300 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-13369 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2002 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14269 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17496 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
900 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15494 usd
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-29
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zi7wu6BxAlA8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_864_zDN75oflll68">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2019Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
10000000 shares
us-gaap Development Costs
DevelopmentCosts
0 usd
CY2022Q4 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
76300 usd
CY2022Q1 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
59000 usd
us-gaap Net Income Loss
NetIncomeLoss
-29397 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-269099 usd
CY2022Q4 ACHN Working Capital
WorkingCapital
-79493 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
4000 usd
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5600 usd
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Net operation losses (“NOLs”) can be carried forever based on the 2017 Tax Cuts and Jobs Act
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
31323 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
39778 usd

Files In Submission

Name View Source Status
form10-q_htm.xml Edgar Link completed
0001493152-23-004389-index-headers.html Edgar Link pending
0001493152-23-004389-index.html Edgar Link pending
0001493152-23-004389.txt Edgar Link pending
0001493152-23-004389-xbrl.zip Edgar Link pending
achn-20221231.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
achn-20221231_cal.xml Edgar Link unprocessable
achn-20221231_def.xml Edgar Link unprocessable
achn-20221231_lab.xml Edgar Link unprocessable
achn-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending